Trials / Unknown
UnknownNCT03173287
Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI
Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 63 (estimated)
- Sponsor
- University Hospital, Clermont-Ferrand · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Quantification of hepatic fibrosis by IVIM sequences in 1.5T MRI.
Detailed description
Early and accurate diagnosis of hepatic fibrosis in patients with chronic liver disease is essential and essential. This assessment could be performed by a non-invasive MRI method. The main objective of this study is to show that the measured perfusion-related scattering value (D \*) is related to the hepatic fibrosis stage. Secondary objectives * Evaluation of infusion fraction (f) and fibrosis stage. * Evaluation of molecular diffusion (D) and fibrosis stage. * Evaluation of ADC and fibrosis stage. * Assess whether there is a link between the etiology of fibrosis and the value of the diffusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Quantification of liver fibrosis | Procedure MRI and liver biopsy |
Timeline
- Start date
- 2017-03-01
- Primary completion
- 2017-03-01
- Completion
- 2018-11-01
- First posted
- 2017-06-01
- Last updated
- 2017-06-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03173287. Inclusion in this directory is not an endorsement.